The primary objective of this study is to reliably estimate the difference in blood pressure control of a technology-enabled solution for blood pressure (BP) management over usual care. The study will also assess patient and provider satisfaction with the solution. Finally, the investigators will estimate the economic impact of the intervention in terms of resource utilization.
The study design is a non-blinded pragmatic cluster-randomized controlled trial with a single intervention. Participants with uncontrolled hypertension will be identified from a randomly selected group of primary care clinics. Participants from half of the clinics will be enrolled in the intervention arm while the others will receive usual care. Participants in the intervention arm will undergo a series of software-driven medication initiation and titration steps until they reach a blood pressure target of systolic blood pressure \< 130 mmHg and diastolic blood pressure \< 80 mmHg. Participants will be subsequently monitored for up to 12 more months.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
1,500
The intervention will consist of a technology-enabled remote hypertension management program.
Difference in SBP change
Difference in mean change in systolic blood pressure (SBP)
Time frame: 6 months after enrollment
HEDIS proportion
Difference in the proportion of patients meeting HEDIS definition of controlled hypertension (SBP \< 140 AND DBP \< 90) between intervention and usual care: overall and by patient group and by age, race, sex strata
Time frame: 6 months after enrollment
Difference in DBP change
Difference in mean change in diastolic blood pressure (DBP)
Time frame: 6 months after enrollment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.